Targeting the proteasome pathway with bortezomib in patients with mantle cell (MCL) and follicular lymphoma (FL) produces prolonged progression free survival among responding patients: Results of a multicenter phase II experience Meeting Abstract

  

Authors:	O'connor, O.; Wright, J.; Moskowitz, C.; Straus, D.; Portlock, C.; Hamlin, P.; Neylon, E.; Evans, A.; Winter, J.; Gordon, L.; Koc, O.; Horvath, N.; Blumel, S.; Vose, J.; Schenkein, D.; Zelenetz, A.
Abstract Title:	Targeting the proteasome pathway with bortezomib in patients with mantle cell (MCL) and follicular lymphoma (FL) produces prolonged progression free survival among responding patients: Results of a multicenter phase II experience
Meeting Title:	9th International Conference on Malignant Lymphoma
Journal Title:	Annals of Oncology
Volume:	16
Issue:	Suppl. 5
Meeting Dates:	2005 Jun 9-11
Meeting Location:	Lugano, Switzerland
ISSN:	0923-7534
Publisher:	Oxford University Press
Date Published:	2005-06-01
Start Page:	v66
Language:	English
ACCESSION:	WOS:000233670100100
PROVIDER:	wos
PUBMED:	15972784
DOI:	10.1093/annonc/mdi559
Notes:	Meeting Abstract: 099 - Oral Presentations: 19. New Agents - 9th International Conference on Malignant Lymphoma - JUN 09-11, 2005 - Lugano, SWITZERLAND - "Source: Wos"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/44798